Letter to the Editor: 3D Printing Has an Imperative Role in Colitis Management
- 1 October 2022
- journal article
- letter
- Published by Mary Ann Liebert Inc in ASSAY and Drug Development Technologies
- Vol. 20 (7), 295-297
- https://doi.org/10.1089/adt.2022.078
Abstract
ASSAY and Drug Development TechnologiesKeywords
This publication has 15 references indexed in Scilit:
- Development of Personalized Colonic Drug Delivery Systems Prepared by 3D-Printing TechnologyKey Engineering Materials, 2021
- 3D printed systems for colon-specific delivery of camptothecin-loaded chitosan micellesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- 3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial statusJournal of Drug Targeting, 2021
- Development and characterization of enteric coated pectin pellets containing mesalamine and Saccharomyces boulardii for specific inflamed colon: In vitro and in vivo evaluationJournal of Drug Delivery Science and Technology, 2021
- 3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel DiseaseBiomedicines, 2020
- Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative ColitisCurrent Nanomedicine, 2020
- 3D printed tacrolimus suppositories for the treatment of ulcerative colitisAsian Journal of Pharmaceutical Sciences, 2020
- A Treat-to-Target Update in Ulcerative Colitis: A Systematic ReviewThe American Journal of Gastroenterology, 2019
- Pharmacotherapy of ulcerative colitis – current status and emerging trendsJournal of Basic and Clinical Physiology and Pharmacology, 2018
- New treatment strategies for ulcerative colitisExpert Review of Clinical Immunology, 2017